First patients dosed with Fasenra in three dermatology trials
With the addition of the new dermatology trials, Fasenra is now being evaluated in nine different indications associated with eosinophilic immune dysfunction.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
